Abstract
Hematopoietic stem cell transplantation (HSCT) can be curative in a large variety of selected malignant and non malignant diseases. Umbilical cord blood transplantation (UCBT) has extended the availability of allogeneic hematopoietic stem cell transplantation (HSCT) to patients who would not otherwise be eligible for this curative approach. The first successful UCBT from an HLA-identical sibling in a child with severe Fanconi’s anemia was reported by Gluckman et al. in 1989 [1]. This first success opened the way to a new field in the domain of allogeneic HSCT as it showed that: (1) a single umbilical cord blood contained enough hematopoietic stem cells to reconstitute definitely the host lympho-hematopoietic compartment; (2) an umbilical cord blood unit could be collected at birth without any harm to the new-born infant, and (3) umbilical cord blood hematopoietic stem cells could be cryopreserved and transplanted in a myeloablated host after thawing without losing their repopulating capacity. Since, our knowledge on the biological characteristics of umbilical cord blood cells has increased, emphasizing the advantages of using umbilical cord blood stem cells for transplant. Simultaneously, umbilical cord blood banks (CBB) have been established for related or unrelated UCBT with more than 500,000 units available and more than 20,000 umbilical cord blood transplants performed in children and in adults with malignant and non malignant diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gluckman E, Broxmeyer HE, Auerbach AD et al (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321:1174–1178
Barker JN, Krepski TP, DeFor T et al (2002) Searching for unrelated donor hematopoietic stem cell grafts: availability and speed of umbilical cord blood versus bone marrow. Biol Blood Marrow Transplant 8:257–260
Frassoni F, Podesta M, Maccario R, Giorgiani G, Zecca M, Bacigalupo A, Piaggio G, Locatelli F (2003) Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood 102:1138–1141
Rocha V, Wagner JE, Sobocinski KA et al (2000) Graft-versus-host disease in children who have received a cord blood or bone marrow transplant from an HLA-identical sibling. N Engl J Med 342:1846–1854
Cairo MS, Wagner EL, Fraser J, Cohen G, van de Ven C, Carter SL, Kernan NA, Kurtzberg J (2005) Characterization of banked umbilical cord blood hematopoietic progenitor cells and lymphocyte subsets and correlation with ethnicity, birth weight, sex, and type of delivery: a cord blood transplantation (COLBT) study report. Transfusion 45:856–866
Ballen KK, Kurtzberg J, Lane TA, Lindgren BR, Miller JP, Nagan D, Newman B, Rupp N, Haley NR (2004) Racial diversity with high nucleated cell counts and CD34 counts achieved in a national network of cord blood banks. Biol Blood Marrow transplant 10:269–275
Wernet P (2008) The Netcord inventory and use [Netcord web site]. Oct 2008. Available at: https://office.de.netcord.org/inventory.gif
NETCORD 3rd (2006) FACT - NETCORD - International Standards for cord blood collection, processing, testing, banking, selection, and release, 3rd edition, Dec 2006
NETCORD CBB 2008: NETCORD CBB Guidance Manual 03/03/08 Guidance derived from meetings with the Scientific Experts Committee and the European Commission
Rubinstein P, Dobrila L, Rosenfield RE, Adamson JW, Migliaccio G, Migliaccio AR, Taylor PE, Stevens CE (1995) Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. PNAS 92:10119–10122
Jones J, Stevens CE, Rubinstein P, Robertazzi RR, Kerr A, Cabbad MF (2003) Obstetrics predictors of placental/umbilical cord blood volume for transplantation. Am J Obstet Gynecol 188:503–509
Rebulla P, Lecchi L, Porretti L, Poli F, Ratti I, Mozzi F, Sirchia G (1999) Practical placental blood banking. Transfusion Medicine Reviews 13: 205–226
Solves P, Mirabet V, Planelles D, Carbonnell-Uberos F, Roig R (2008) Influence of volume reduction and cryopreservation methodologies on quality of thawed umbilical cord blood units for transplantation. Cryobiology 56:152–158
Kodera Y (2008) The Japan marrow donor program, the Japan cord blood bank network and the Asia blood and marrow registry. Bone Marrow Transplant 42(1):56
Davey S, Armitage S, Rocha V, Garnier F, Brown J, Brown CJ, Warwick R, Fehily D, Watt S, Gluckman E, Vora A, Contreras M, Navarrete C (2004) The London Cord blood Bank: analysis of banking and transplantation outcome. Br J Haematol 125:358–365
Howard DH, Meltzer D, Kollman C, Maiers M, Logan B, Gragert L, Setterholm M, Horowitz MM (2008) Use of cost effectiveness analysis to determine inventory size for a national cord blood bank. Med Dec making 28:243–253
Reed W, Smith R, Dekovic F, et al (2003) Comprehensive banking of sibling donor cord blood for children with malignant and non malignant disease. Blood 101:351–357
Lubin B, Shearer WT American academy of pediatrics Section on Hematology/Oncology (2007) Cord blood banking for potential future transplantation. Pediatrics 119:165–170
ASBMT position statement (2008) Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 14:364–362
Ballen KK, Barker JN, Stewart SK, Greene MF, Lane TA (2008) Collection and preservation of cord blood for personal use. Biol Blood Marrow Transplant 14:356–363
Sullivan MJ (2008) Banking on cord blood stem cells. Nat Rev Cancer 8:554–563
Hayani A, Lampeter E, Viswanatha D, Morgan D, Salvi SN (2007) First report of autologous cord blood transplantation in the treatment of a child with leukemia. Pediatrics 119:296–300
Gluckman E, Rocha V, Boyer-Chammard A et al (1997) Outcome of cord blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337:373–381
Rubinstein P, Carrier C, Scaradavou A et al (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339:1565–1577
Wagner JE, Barker JN, DeFor TE et al (2002) Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100:1611–1618
WMDA (2007) World marrow donor association guidelines for use of HLA nomenclature and its validation in the data exchange among hematopoietic stem cell donor registries and cord blood banks. Bone Marrow Transplant 39:737–741
Kamani N, Spellman S, Hurley CK, Barker JN, Smith FO, Oudshoorn M, Bray R, Smith A, Williams TM, Logan B, Eapen M, Anasetti C, Setterholm M, Confer DL, National Marrow Donor Program (2008) State of the art: HLA matching and outcome of unrelated donor unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant 14:1–6
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Netherlands
About this chapter
Cite this chapter
Gluckman, E. (2010). Banking of Cord Blood. In: Galea, G. (eds) Essentials of Tissue Banking. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9142-0_3
Download citation
DOI: https://doi.org/10.1007/978-90-481-9142-0_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9141-3
Online ISBN: 978-90-481-9142-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)